United States: What's New In Washington - September 2018

Following a truncated August recess, the House and the Senate returned to Washington after Labor Day with a full plate of legislative items to address prior to the end of the fiscal year on September 30. That list includes funding the federal government, reauthorizing the Federal Aviation Administration, approving the Water Infrastructure Act and wrapping up negotiations over the Farm Bill, which is currently in a conference committee (see Farm Bill section for more information).

The Senate Judiciary Committee spent the first week of September on hearings on the nomination of Judge Brett Kavanaugh to be an Associate Justice of the Supreme Court. A committee vote is expected in the next two weeks, followed by a vote on the Senate floor prior to the commencement of the Supreme Court's next term, which begins on October 1.

The Senate also is expected to pass a comprehensive opioid package with an overwhelming bipartisan margin in the next few days and then will work with the House to reconcile differing versions prior to the House adjournment at the end of September, if possible.

The Senate and the House have had an unusually productive appropriations season, with nine of the 12 annual spending bills moving through the House and the Senate and currently in the process of being reconciled through conference committees. In an attempt to avoid passing another massive, unpopular "omnibus" bill containing all 12 appropriations bills as has been typical in recent years, the House and the Senate have focused on passing the appropriations bills in the form of "minibus" appropriations bills containing multiple bills in each vehicle:

Minibus #1: Energy and Water Development, Military Construction and Veterans Affairs, and Legislative Branch

Minibus #2: Agriculture, Financial Services, Interior and Environment, and Transportation – Housing and Urban Development

Minibus #3: Defense and Labor and Health and Human Services and Education

The House and the Senate are expected to pass minibus #1 in the next few days and are working to pass minibus #3 by the end of the month. It is not clear yet whether minibus #2 will make it to the President's desk prior to September 30. At least three other appropriations bills will not be finalized prior to September 30: (1) Commerce–Justice– Science, (2) State and Foreign Operations, and (3) Homeland Security. The House and the Senate are expected to pass a Continuing Resolution by September 30 to extend funding to cover any unfinished appropriations bills until the lame duck session.

Updates on the Agreement Formerly Known as "NAFTA"

On Friday, August 31, President Trump notified Congress of his intent to enter into a "new" free trade agreement with Mexico—and Canada, if it is willing. In the letter, President Trump touted that this new agreement will ensure market access for U.S. farmers, create a level playing field for U.S. manufacturers as a result of amendments to the agreement's rules of origin, include the toughest and most comprehensive environmental and labor provisions, and improve protection of intellectual property (IP) rights protection. The administration submitted the notification to Congress so that it could give Mexican President Nieto an opportunity to sign the agreement before he leaves office on November 30.

In response to the President's notice to Congress, several senior members urged the administration and Canada to maintain the North American Free Trade Agreement (NAFTA) as a trilateral agreement. House Committee on Ways and Means Chairman Kevin Brady (RTX) noted that Canada needs "to step up and demonstrate that it can take on the ambitious obligations of the agreement." Senate Finance Committee Ranking Member Ron Wyden (DOR) noted that "it is premature for the President to announce he intends to sign a trade agreement when so many difficult issues remain unsolved." Earlier in the week, Senate Finance Trade Subcommittee Chairman John Cornyn (R-TX) noted that "a trilateral agreement is the best path forward." Rep. Bill Pascrell (D-NJ), the ranking member of the Ways and Means Trade Subcommittee, also noted that the final agreement must include Canada. Sen. Pat Toomey (R-PA) also told reporters that he thinks that any final agreement must also include Canada to ensure that the implementation of the agreement receives Trade Promotion Authority (TPA) protection.

In response to U.S. lawmakers' concerns about not including Canada in a final agreement, President Trump warned U.S. lawmakers that he will "simply terminate" the current NAFTA should they interfere in the negotiations. Ranking Member Wyden refuted the President's claim that he could unilaterally withdraw from NAFTA without congressional approval, stating, "The president doesn't have a deal, he doesn't have a plan, and he doesn't even have the power to follow through on his empty threats. The president needs to take a look at the Constitution—it gives Congress authority over trade. The president cannot pull America out of NAFTA without Congress's permission."

While negotiations with Canada resumed on Wednesday, September 5, the two countries still have a number of issues to address, including dairy market access, trade remedy dispute settlement procedures, government procurement and IP rights. Negotiations between the two countries had stalled on Friday, August 31, amidst news reports of President Trump's leaked comments indicating that he would never make concessions to Canada. President Trump later confirmed the comments in a Tweet, where he indicated that "at least Canada knows where I stand." Canadian Prime Minister Justin Trudeau responded before the September negotiations began, "As I've said, we will not sign a deal that is bad for Canadians." He signaled that Canada will not back down on dispute settlement and added that the deal must maintain a carveout that excludes "cultural industries" from obligations under the agreement.

The administration is required under TPA rules to provide the full text of the new agreement to Congress at least 60 days before it is signed. According to that timing, the Office of the U.S. Trade Representative and negotiators from all three NAFTA countries must release the text, with or without Canada included, by September 30. (Follow our TPA timeline here as additional milestones are reached.) The Trump administration remains confident that it will be able to come to an agreement with at least Mexico in the next few weeks to provide Congress with written text.

HHS Marks 100 Days Since Drug Pricing Blueprint

On August 22, HHS released a brief report summarizing the actions that the agency has taken on drug pricing in the 100 days since the administration published its American Patients First blueprint. The report noted several manufacturers' decisions to roll back or delay certain drug price increases, as well as the FDA's continued efforts to streamline generic drug approvals.

The Centers for Medicare and Medicaid Services (CMS) recently took several actions to address drug prices, some of which are mentioned in the report. On August 7, the agency announced that it will permit Medicare Advantage plans to have the option of applying step therapy for physician-administered and other Part B drugs beginning on January 1, 2019. Additionally, on August 29, CMS issued guidance to allow Medicare Part D plan sponsors to use indication-based formulary design beginning in 2020. According to CMS, this change will help strengthen plans' negotiating leverage with manufacturers.

Looking ahead, the Office of Management and Budget (OMB) is now reviewing an HHS Office of Inspector General proposed rule that would both eliminate and create new safe harbor protections related to drug rebates for pharmacy benefit managers. FDA Commissioner Scott Gottlieb and HHS Secretary Alex Azar have both discussed the possibility of re-examining the safe harbors for drug rebates.

OMB also is reviewing a proposed rule on drug pricing transparency, which is expected to propose requiring the disclosure of price information in direct-to-consumer advertising by pharmaceutical manufacturers. Additionally, the Labor–HHS appropriations bill passed by the Senate last month includes an amendment to fund implementation of such a requirement.

Farm Bill Negotiations Continue

Legislators continue to negotiate legislation to reauthorize federal agriculture programs. The House passed its "Farm Bill" in late June. The legislation contained enhanced work requirements for recipients of the Supplemental Nutrition Assistance Program (SNAP). House passage came after a significant debate and fell largely along party lines, with some Republicans voting with Democrats against the bill. The Senate approved its version a week later by a bipartisan majority of 86-11, following committee mark-up that largely avoided partisan disagreements.

Staff from both chambers met through the recess to reach a negotiated agreement, but several issues remain unresolved. Beyond the enhanced SNAP work requirements, crop insurance and commodity prices also pose challenges to reaching a deal. The Trump administration's ongoing trade negotiations have created an additional wrinkle in completing talks over the Farm Bill. Retaliatory tariffs from other countries have, in part, been aimed at the U.S. agriculture sector.

Congress will need to pass a new Farm Bill or an extension of the current law before it expires on September 30. Some observers believe that legislators will choose to pursue the latter option, with a temporary extension giving negotiators additional time to hammer out a compromise. If Congress pursues a short-term extension, it is likely to go until after election day and into the lame duck session. Some analysts predict that the extension could go even longer, possibly into the new Congress.

FCC Seeks Input on Expanding Telehealth Funding Opportunities

On August 2, the Federal Communications Commission (FCC) released a Notice of Inquiry in which it is seeking comment on establishing a new $100 million "Connected Care Pilot Program" to support telehealth funding for health care providers to reach low-income Americans and veterans, with a focus on those living in rural areas. The FCC seeks comment on a number of issues related to establishing the pilot program, including its budget, design and types of telehealth pilot projects that should be funded. In addition, the FCC seeks comment on the eligibility criteria for participating health care providers, broadband service providers, and the broadband services and other communications services and equipment that should be supported. The FCC also seeks comment on whether it should require health care providers to partner with an eligible telecommunications carrier on their application. Comments were due September 10, and reply comments are due October 10.

New California Privacy Law May Increase Pressure for Federal Legislation

As part of its August session, the California State Legislature adopted modifications to the California Consumer Privacy Act of 2018 (CCPA) to tighten certain aspects concerning what would be considered a violation of the law, the standard for what is considered a violation of the law and limitation of consumer lawsuits to instances where there had been a breach. The amended language also defers the timing for enforcement, preventing the state attorney general from enforcing the law until July 2020 or six months after the regulations are final, whichever is first. The effort fell far short of changes that many had urged the legislature to make, and, as a result, the call for federal action will escalate. While there are a number of bills pending before the Congress, it is unlikely that they will move before the end of this year, but efforts are under way to begin establishing the framework on legislation for the next Congress. The CCPA becomes effective July 1, 2020.

Recent Losses for Trump Administration EPA

August was a particularly difficult month for the Trump administration Environmental Protection Agency (EPA), which suffered tough losses on some high-profile matters in which the agency sought to reverse course on Obama administration EPA actions. The losses that we highlight here were suffered on actions taken since the beginning of the Trump administration and are losses that stemmed from actions in which the various courts found that the agency failed to supply a reasoned analysis for changing its course, a prerequisite for policy change in administrative rulemaking. See Motor Vehicles Mfgrs. Ass'n of U.S., Inc. v. State Farm Mut. Auto Ins. Co., 463 U.S. 29, 57 (1983):

  1. On August 17, 2018, the agency's action to delay the effective date of the 2017 Risk Management Program Rule amendments issued by EPA at the end of the Obama administration was vacated by the U.S. Court of Appeals for the District of Columbia Circuit. Air Alliance Houston v. EPA, No. 17-1155 (D.C. Cir. 2018). In so doing, the court accused the agency of making a "mockery" of the law. Id. at 28. For more detail, see our alert here.
  2. On August 16, 2018, EPA's rule attempting to suspend the implementation of the Clean Water Rule (CWR), also referred to as the Waters of the United States Rule, was enjoined following a finding that the agency suspended the rule in violation of the Administrative Procedure Act (APA) by precluding an opportunity for meaningful public comment. S.C. Coastal Conservation League v. Pruitt, No. 2-18-cv-330-DCN (D.S.C. 2018). In particular, the court found that EPA acted improperly by restricting comment to the narrow question of whether it was desirable and appropriate to delay implementation of the CWR and specifically precluding comment on the substance of the rule or its predecessor rule that would have purportedly been reinstated by the suspension rule. Id. at 7.
  3. On August 9, 2018, the agency was found to have erred in denying a petition to ban the use of the pesticide chlorpyrifos, finding that there was "no justification" for its March 2017 decision. League of United Latin American Citizens v. Wheeler, 899 F.3d 814 (9th Cir. 2018). After grappling with a jurisdictional question mired in the nuances of the APA, the 9th Circuit found that it had authority to act and summarily rejected EPA's argument that there remained "significant uncertainty" as to the health effects of the pesticide, noting that the agency "cannot refuse to act 'because of the possibility of contradiction in the future by evidence unavailable at the time of action—a possibility that will always be present.'" Id. at 32.

2018 Midterm Elections: Precedents & Outlook

In less than two months, the public will go to the polls to select representation for the 116th Congress, which begins in January 2019. All 435 seats in the House and a third of the seats in the Senate will be up for reelection, giving voters the opportunity to potentially reshape policy-making for the next two years.

Akin Gump Strauss Hauer & Feld LLP recently published a report that seeks to provide insight into the upcoming 2018 midterm elections by delving into the historical and political patterns that have shaped previous midterm contests. The report looks at how presidential popularity and historical precedent can shape outcomes. It explores the current state of play of the overall dynamics in the House and Senate races. Finally, the report looks at each party's strategy for success this fall. (Note that numbers reflected in the report are accurate as of the original publication date of August 21, 2018.)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
Email Address
Company Name
Confirm Password
Mondaq Newsalert
Select Topics
Select Regions
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions